SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-103879
Filing Date
2019-04-11
Accepted
2019-04-11 16:21:55
Documents
7
Effectiveness Date
2019-04-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d713258ddefa14a.htm DEFA14A 43340
2 GRAPHIC g713258g00x42.jpg GRAPHIC 1822
3 GRAPHIC g713258g40m61.jpg GRAPHIC 1827
4 GRAPHIC g713258g64c31.jpg GRAPHIC 6290
5 GRAPHIC g713258g69z84.jpg GRAPHIC 1822
6 GRAPHIC g713258g85v43.jpg GRAPHIC 1813
7 GRAPHIC g713258naa02a.jpg GRAPHIC 3663
  Complete submission text file 0001193125-19-103879.txt   69084
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37553 | Film No.: 19744080
SIC: 2836 Biological Products, (No Diagnostic Substances)